Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.4 USD | +2.20% | +0.90% | +19.59% |
05-07 | CytomX Therapeutics, Inc. Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with Keytruda® (pembrolizumab) | CI |
05-02 | Merck: encouraging results in gastric cancer | CF |